Digital Medicine Society, Boston, MA, United States.
Enlightening Results LLC, West Caldwell, NJ, United States.
J Med Internet Res. 2023 Jan 4;25:e43404. doi: 10.2196/43404.
Although health care delivery is becoming increasingly digitized, driven by the pursuit of improved access, equity, efficiency, and effectiveness, progress does not appear to be equally distributed across therapeutic areas. Oncology is renowned for leading innovation in research and in care; digital pathology, digital radiology, real-world data, next-generation sequencing, patient-reported outcomes, and precision approaches driven by complex data and biomarkers are hallmarks of the field. However, remote patient monitoring, decentralized approaches to care and research, "hospital at home," and machine learning techniques have yet to be broadly deployed to improve cancer care. In response, the Digital Medicine Society and Moffitt Cancer Center convened a multistakeholder roundtable discussion to bring together leading experts in cancer care and digital innovation. This viewpoint highlights the findings from these discussions, in which experts agreed that digital innovation is lagging in oncology relative to other therapeutic areas. It reports that this lag is most likely attributed to poor articulation of the challenges in cancer care and research best suited to digital solutions, lack of incentives and support, and missing standardized infrastructure to implement digital innovations. It concludes with suggestions for actions needed to bring the promise of digitization to cancer care to improve lives.
尽管医疗保健服务正日益数字化,其驱动力是改善可及性、公平性、效率和效果,但进展似乎并未在各个治疗领域均衡分布。肿瘤学以引领研究和护理创新而闻名;数字病理学、数字放射学、真实世界数据、下一代测序、患者报告结果和基于复杂数据和生物标志物的精准方法是该领域的标志。然而,远程患者监测、分散式护理和研究方法、“家庭式医院”以及机器学习技术尚未广泛部署,以改善癌症护理。为此,数字医学学会和莫菲特癌症中心召集了一次多方利益相关者圆桌讨论,汇集了癌症护理和数字创新领域的领先专家。本观点重点介绍了这些讨论的结果,专家们一致认为,与其他治疗领域相比,数字创新在肿瘤学领域滞后。报告称,这种滞后最有可能归因于对最适合数字解决方案的癌症护理和研究挑战的表述不佳、缺乏激励和支持,以及缺乏实施数字创新的标准化基础设施。最后提出了一些行动建议,以期将数字化的承诺应用于癌症护理,以改善人们的生活。